Baiyunshan subsidiary gains Vietnam approval for Angong Niuhuang Pills

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced its wholly-owned subsidiary, Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. (Zhongyi Pharmaceutical), has received a registration certificate for Angong Niuhuang Pills from the Vietnamese Ministry of Health's Traditional Medicine Administration. The registration number is VNCT-00006-25, and the manufacturer is Zhongyi Pharmaceutical. TNHH NEWSEEN COAST will sell the product in Vietnam.

The application for Angong Niuhuang Pills was submitted on June 20, 2024. This traditional Chinese medicine is indicated for clearing heat and detoxifying, calming fright, and restoring consciousness. According to MineNet data, in 2024, sales of Angong Niuhuang Pills in Chinese cities, county-level public hospitals, and online pharmacies totaled RMB498,242萬元. In the same year, Zhongyi Pharmaceutical's sales revenue for Angong Niuhuang Pills was RMB15,611.83萬元.

As of the announcement date, Zhongyi Pharmaceutical has invested approximately RMB3,279.81萬元 (unaudited) in the research and development of Angong Niuhuang Pills. This registration is expected to expand Zhongyi Pharmaceutical's business in Vietnam and enhance the company's market competitiveness, though it is not anticipated to significantly impact current period performance.